The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 6, 2004, Pages 799-808

  Pistone Creydt, V ^a   Fernandez Miyakawa, M ^a   Martin F ^a   Zotta, E ^a   Silberstein, C ^a   Ibarra, C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

B subunit; Diarrhea; Hemolytic uremic syndrome; Shiga toxin 2; Water transport

Indexed keywords

BACTERIAL TOXIN; BACTERIAL VACCINE; CANCER VACCINE; SHIGA TOXIN; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; COLON ABSORPTION; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; ELECTRIC POTENTIAL; ELECTRICAL PARAMETERS; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE ABSORPTION; INTESTINE LOOP; INTESTINE SECRETION; MALE; NONHUMAN; PURIFICATION; RAT; SHORT CIRCUIT CURRENT; TIME; VERO CELL; WATER ABSORPTION;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 3042539850     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2004000600004     Document Type: Article

References (31)

1. Griffin PM & Tauxe RV (1991). The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiologic Reviews, 13: 60-98.
2. Richardson SE, Karmali MA, Becker LE & Smith CR (1988). The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli. Human Pathology, 19: 1102-1110.
3. López EL, Díaz M, Grinstein S et al. (1989). Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. Journal of Infectious Diseases, 160: 469-475.
4. Rivas M, Balbi L, Milliwebsky E, García B, Tous M, Leardini N, Prieto M, Chillemi G & De Principi M (1998). Sí ndrome urémico hemolítico en niños de Mendoza, Argentina: Su asociación con la infección por Escherichia coli productor de toxina Shiga. Medicina, 58: 1-7.
5. Cohen A, Hannigan GE, Williams BRG & Lingwood CA (1987). Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. Journal of Biological Chemistry, 262: 17088-17099.
6. Sandvig K, Olsnes S, Brown JE, Petersen OW & van Deurs B (1989). Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. Journal of Cell Biology, 108: 1331-1343.
7. Obrig TG, Moran TP & Brown JE (1987). The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochemical Journal, 244: 287-294.
8. Ching JC, Jones NL, Ceponis PJ, Karmali MA & Sherman PM (2002). Escherichia coli Shiga-like toxins induce apoptosis and cleavage of poly (ADP-ribose) polymerase via in vitro activation of caspases. Infection and Immunity, 70: 4669-4677.
9. Jones NL, Islur A, Haq R, Mascarenhas M, Karmali MA, Perdue MH, Zanke BW & Sherman PM (2000). Escherichia coli Shiga toxin induces apoptosis in epithelial cells that is regulated by the Bcl-2 family. American Journal of Physiology, 278: 811-819.
10. Abreu MT, Palladino AA, Arnold ET, Kwon RS & McRoberts JA (2000). Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells. Gastroenterology, 119: 1524-1536.
11. Acheson DWK, Moore R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E & Kelusch GT (1996). Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infection and Immunity, 64: 3294-3300.
12. Rodney A, Moxley L & Francis DH (1998). Overview of animal models. In: Kaper JB & O'Brien AD (Editors), Escherichia coli O157:H7 and other Shiga Toxin-Producing E. coli Strains. American Society for Microbiology, Washington, DC, USA.
13. Keenan KP, Sharpnack DD, Collins H, Formal SB & O'Brien AD (1986). Morphologic evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. American Journal of Pathology, 125: 69-80.
14. Fiorito P, Burgos JM, Miyakawa MF, Rivas M, Chillemi G, Berkowski D, Zotta E, Silberstein C & Ibarra C (2000). Effect of Shiga toxin 2 on water and ion transport in human colon in vitro. Digestive Diseases and Sciences, 45: 480-486.
15. Pistone Creydt V, Miyakawa MF, Martín F, Zotta E, Silberstein C & Ibarra C (2002). La subunidad B de Stx2 enterohemorrágica tiene efecto citotóxico sobre colon y riñón humano. XVI Congreso Latinoamericano de Microbiología, La Habana, Cuba, 14 (Symposium).
16. Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T & Wiels J (1993). Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Research, 53: 5314-5319.
17. Marcato P, Mulvey G & Armstrong GD (2002). Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells. Infection and Immunity, 70: 1279-1286.
18. Calderwood SB, Acheson DW, Goldberg MB, Boyko SA & Donohue-Rolfe A (1990). A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit. Infection and Immunity, 58: 2977-2982.
19. Marcato P, Mulvey G, Read RJ, Helm KV, Nation PN & Armstrong GD (2001). Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. Journal of Infectious Diseases, 183: 435-443.
20. Kojio S, Zhang H, Ohmura M, Gondaira F, Kobayashi N & Yamamoto T (2000). Caspase-3 activation and apoptosis induction coupled with the retrograde transport of Shiga toxin: inhibition by brefeldin A. FEMS Immunology and Medical Microbiology, 29: 275-281.
21. Sambrook J, Fritsch EF & Maniatis T (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
22. Newland JW, Strockbine NA, Miller SF, O'Brien AD & Holmes RK (1985). Cloning of Shiga-like toxin converting phage of Escherichia coli. Science, 230: 179-181.
23. Karmali MA, Petric M, Lim C, Cheung R & Arbur GS (1985). The association between hemolytic uremic syndrome and infection by Verotoxin producing Escherichia coli. Journal of Infectious Diseases, 151: 775-782.
24. Pina DG, Gomez J, Villar E, Johannes L & Shanyrov L (2003). Thermodynamic analysis of the structural stability of the Shiga toxin B subunit. Biochemistry, 42: 9498-9506.
25. Riley LW, Remis RS, Helgerson SD et al. (1983). Hemorrhagic colitis associated with a rare Escherichia coli serotype. New England Journal of Medicine, 308: 681-685.
26. Nataro JP & Kaper JB (1998). Diarrheagenic Escherichia coli. Clinical Microbiology Reviews, 11: 142-201.
27. Li Z, Bell C, Buret A, Robins-Browne R, Stiel D & O'Loughlin E (1993). The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits. Gastroenterology, 104: 467-474.
28. Kunzelmann K & Mall M (2002). Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiological Reviews, 82: 245-289.
29. Capozzo AB, Pistone V, Dran G, Fernandez G, Gomez S, Bentancor L, Rubel C, Ibarra C, Isturiz M & Palermo M (2003). Development of DNA vaccine against hemolytic uremic syndrome in a murine model. Infection and Immunity, 71: 3971-3978.
30. Haicheur N, Bismuth E, Bosset S et al. (2000). The B subunit of Shiga toxin to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. Journal of Immunology, 165: 3301-3308.
31. Lee RS, Tartour E, van der Bruggen P, Vantomme V, Joyeux I, Goud B, Fridman WH & Johannes L (1998). Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. European Journal of Immunology, 28: 2726-2737.